Drug-Target Information | ||||||||
---|---|---|---|---|---|---|---|---|
Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
golimumab | tumor necrosis factor | biotech | Successful target | TTD , drugbank , DGIDB | Ankylosing spondylitis[MeSHID:D013167] Rheumatoid Arthritis[MeSHID:D001172] Juvenile arthritis[MeSHID:D001171] Unmarried[MeSHID:D012847] Arthritis Psoriatic[MeSHID:D015535] Ulcerative Colitis[MeSHID:D003093] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inflammatory Bowel Diseases[MeSHID:D015212] |
4.68 | approved | antibody |
golimumab | tumor necrosis factor | biotech | Successful target | TTD , drugbank , DGIDB | Ankylosing spondylitis[MeSHID:D013167] Rheumatoid Arthritis[MeSHID:D001172] Juvenile arthritis[MeSHID:D001171] Unmarried[MeSHID:D012847] Arthritis Psoriatic[MeSHID:D015535] Ulcerative Colitis[MeSHID:D003093] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] Inflammatory Bowel Diseases[MeSHID:D015212] |
4.68 | approved | antibody,inhibitor |
click here to return to the previous page |